The UK Kidney Association

The UK Renal Registry 26th Annual Report has been published and is now available, packed with vital insights and trends in kidney care across the UK. This report offers invaluable information on the treatment and care of 70,000+ patients with chronic kidney disease based on data collected up to December 2022. Highlights: 🔹 8,254 people started KRT in 2022 - 22 people every day. 🔹 Mortality within a year: 1 in 13 under 65, 1 in 6 over 65. 🔹 Black individuals start KRT 8 years earlier than White individuals. 🔹 KRT population has grown 20% in the last decade. Our data drives improvements in care quality and accessibility. Dive into the full report for more: https://bit.ly/3zAjw0D

Join our leadership board at the UK Kidney Association! Are you passionate about influencing national policy and championing multi-professional healthcare teams? UKKA is seeking a new Trustee from an MPT background to join our leadership board. Key Responsibilities: 👥 Co-chairing the Professional Council to foster collaboration among professional groups. 📈 Working with our Membership Officer to understand member needs and drive growth. 🗣️ Developing leadership capabilities within UKKA. 🏆 Streamlining award nominations and overseeing committee appointments. 📝 Supporting corporate governance and policy consultations. 📣 Representing UKKA at policy forums and enhancing communication strategies. Apply before 2 September! ➡️ https://bit.ly/3xSQiJG

🚨 Have You Read Our Latest AKI Report? 🚨 View the latest insights into Acute Kidney Injury (AKI) across England, presented in our comprehensive #AKI Annual Report: https://bit.ly/3VWSUzz This latest report is noteworthy for its extensive data coverage, with contributions from 98% of laboratories across England, compared to 87% in the initial 2020 report. Near-complete coverage offers a more accurate and reliable picture of the incidence and impact of AKI on the population. 📈 Key Findings: 🔹Significant geographical disparities in AKI rates across England, highlighting the impact of local healthcare practices, resource availability, and socio-economic factors. 🔹In 2022, over half a million people experienced at least one episode of AKI, with 68.6% of these cases being community-acquired. 🔹AKI incidence was higher in deprived areas (23%) compared to affluent regions (17%). 🔍 Outcomes & Challenges: 🔹Most AKI cases (70%) did not progress beyond stage 1, indicating a less severe impact for the majority of patients. 🔹Despite this, AKI remains a significant contributor to hospital admissions and mortality, particularly for more severe cases. 🔹Patients with AKI had longer hospital stays, with emergency admissions averaging 13 days compared to 10 days for planned admissions. 🔹The risk of death within 30 days of an AKI episode increased with severity, from 13% for stage 1 to 35% for stage 3. 🔹Mortality was higher among patients who developed AKI in the hospital, with more deaths occurring during the winter months. 🔭 Looking Ahead: Despite advances in data collection and understanding AKI’s impact, overall AKI rates and associated mortality have remained unchanged since 2018. This underscores the urgent need for enhanced prevention, detection, and management strategies for AKI. 📚 For Healthcare Professionals, Policymakers, and Researchers: The AKI Annual Report is an invaluable resource, offering the latest information on AKI rates and outcomes. Access the AKI data portal for continuous updates: https://lnkd.in/ebQvj8qe 📥 Download the full AKI report and patient summary here: https://lnkd.in/ecEfA8KF #Healthcare #UKHealth #MedicalResearch #HealthDisparities #PublicHealth #UKKA #KidneyHealth #MedicalInsights

📢 Reflecting on the Success of UK Kidney Week 2024 in Edinburgh! 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Two weeks have flown by since we wrapped up UKKW 2024, and what an incredible conference it was! With a record-breaking 1,495 attendees, the energy and enthusiasm were palpable. Here are some highlights: ✨ 223 inspiring speakers ✨ 432 innovative posters ✨ 96 compelling oral abstracts ✨ 60 exhibitors displaying the latest in healthcare ✨ 68 sessions filled with knowledge and collaboration ✨ 3 powerful plenaries ft fantastic keynote speakers Relive the moments through our event photos, now available online: ukkw.org/photos Don’t forget to check out all the UKKW abstracts on our website: ukkw.org/abstracts If you haven’t shared your feedback yet, please check your emails for the link – your insights are invaluable. 📅 And mark your calendars! UKKW 2025 is heading to Bournemouth, 10-12 June. We can’t wait to see you there (right on the beach🏖️) for another unforgettable event!

🌟 Only 3 Days Left to Register for UK Kidney Week 2024! 🌟 Join us in Edinburgh from 11-13 June for the largest gathering of kidney professionals in the UK. This scientific, educational and networking meeting features the latest research, lectures, diverse symposia, presentations and workshops. Don't miss this exceptional opportunity to: 🔹 Engage with colleagues and network with experts 🔹 Explore the latest research and technological innovations 🔹 Attend sessions on renal pathology, nutrition, sustainability, rare diseases, and more Keynote speakers include: 🔸Graham Ellis, Deputy Chief Medical Officer for Scotland 🔸Bruce Guthrie, Professor of General Practice, Usher Institute 🔸Sir Peter Mathieson, Principal and Vice Chancellor, University of Edinburgh 🔸Peter Kotanko, Head of Biomedical Evidence Generation and Renal Research Institute, New York 🔸Morgan Grams, Susan and Morris Mark Professor of Medicine, NYU Grossman School of Medicine Also enjoy a 'touch of tartan' conference dinner, welcome receptions, Scottish ceilidh band, red carpet and photo opportunities! 📅 Registration closes on 27 May. Secure your spot now and be part of the future of kidney healthcare: https://bit.ly/3vTo8gh #UKKW2024 #KidneyHealth #MedicalConference #HealthcareInnovation #Networking #EdinburghEvents #MedicalResearch #KidneyCare

The Kidney PREM 2023 Report is out now! 📣 Explore how people with kidney disease rated their experience of care in 2023. Top scoring areas included: 🔺Privacy & dignity 🔺Patient info 🔺Access Lowest scoring areas were: 🔻Support 🔻Sharing decisions 🔻Transport Read more 👉 https://bit.ly/45vL0zJ

A great response so far to the latest NEPHwork project IGNITE with over 20 centres signed up in the first fortnight! We're keen to get as many UK kidney centres as possible involved to be able to understand current adult kidney biopsy practice and to inform the future direction of travel. 'InvestigatinG kidNey bIopsy pracTice and outcomEs (IGNITE) is a UK-wide project aiming to provide a contemporary snapshot of current UK kidney biopsy practice, pathways and processes including set-up, procedural details, training opportunities and complications. Through contributing data to IGNITE you will help with the understanding of current inter-centre variations and training opportunities in kidney biopsy, and provide data to support the production of best-practice guidance for kidney biopsies across the UK. IGNITE is open to trainees, pre-ST level doctors and medical students. Get your teams involved by signing up here: https://lnkd.in/evYQ9C_Y Find out more about this project: https://bit.ly/3PNGpD3

All exhibition spaces for UK Kidney Week 2024 in Edinburgh have sold out in record time! Thank you to everyone for your overwhelming support. Take a look at this year's lineup of exhibitors and explore the floorplan: https://lnkd.in/eQy3GzAB Missed out on securing a spot? Contact us to join the waitlist and stay informed of any openings and future events. UKKW is taking place 11-13 June at the Edinburgh International Conference Centre.

🌟 Treatments for rare diseases needed to beat kidney failure 🌟 A landmark study by the UK Kidney Association and UCL, leveraging the National Registry of Rare Kidney Diseases (RaDaR) – the world's largest of its kind – highlights the transformative potential of focusing on rare kidney conditions. Findings suggest that targeting these conditions could significantly ease the overall burden of kidney disease on patients and the NHS, offering hope for more effective treatments and reduced dependence on dialysis and transplantation. This research underscores the importance of RaDaR and the role of the UKKA in leading kidney health advancement. It's a call to action for the healthcare community to prioritise rare kidney diseases, potentially revolutionising care and outcomes for thousands. Read more here: https://bit.ly/4chjedE

Only 1 week until #WorldKidneyDay! 💛 ⏳ #Kidney disease might not be top of everyone's minds, but it's time to change that. 💪 Get involved to make a BIG impact: 👉 https://bit.ly/3wGsFTM #KidneysMatter #KidneyDisease